The recent Supreme Court judgment dismissing pharma giant Novartis’ claim for patent protections in India for its award-winning and prohibitively priced anti-leukemia drug Glivec has renewed the focus on accessibly-priced drugs – in particular the failure of the Indian public healthcare system and health policy to ensure affordable drugs for all. Studies show that as much as 70% of health spending in India comes from out-of-pocket payments, with 50-80% of...
More »SEARCH RESULT
Why Novartis case will help innovation-Achal Prabhala and Sudhir Krishnaswamy
-The Hindu The Supreme Court judgment on Glivec is a blow for a patent regime with a higher threshold of inventiveness On April 1, 2013, the Supreme Court upheld the Intellectual Property Appellate Board's decision to deny patent protection to Novartis's application covering a beta crystalline form of imatinib -the medicine Novartis brands as Glivec, and which is very effective against the form of cancer known as chronic myeloid leukaemia (CML). The...
More »PMO refues to give information related to Robert Vadra land deal case -Ashish Tripathi
-The Times of India LUCKNOW: The Prime Minister's Office (PMO) has denied to provide information on Robert Vadra writ petition filed in the Allahabad high court. The public information officer (PIO) of the PMO denied providing notesheet of the case-related file to the petitioner and social activist Nutan Thakur saying that the matter was sub-judice. To this Thakur, wrote to the first appellate authority (FAO) saying that the RTI Act nowhere prohibits...
More »The trial against other accused in 1984 riots case nearing completion-Jiby Kattakayam
-The Hindu Court order will not impact the trial against Panewala: CBI Even as the Sessions court order, rejecting the CBI clean chit to Congress leader Jagdish Tytler ensures that the investigation into the 1984 riots case will continue, the trial against the other accused person in the case, Suresh Kumar alias Panewala, who is charged with murder and rioting, is nearing completion. A CBI source said the agency has completed the examination...
More »HIV, cancer patients seek access to affordable medicines-Aarti Dhar
-The Hindu Protesters see attempt by EU to undermine Indian judiciary in the EU-FTA pact People living with HIV, cancer patient groups and public health activists came out on the streets on Wednesday demanding that India reject the European Union's demands in the European Union-India Free Trade Agreement (EU-India FTA) negotiations. The protests coincide with Prime Minister Manmohan Singh's visit to Germany to meet Chancellor Angela Merkel with the FTA on top of...
More »